1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow JNJ-54175446 150 mg: new trials by email Literature Review of JNJ-54175446 150 mg trials Research Report on JNJ-54175446 150 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects JNJ-54175446 150 mg, JNJ-54175446 600 mg, Midazolam 2 mg - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 16 | 2017-03-14 | 2017-06-08 |
Janssen Research & Development, LLC (1)
Belgium (1)
2016 (1)